Cellular and molecular approaches to osteoporosis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone with increased susceptibility to fractures in focal sites such as femoral neck and lumbar spine. The current challenge is to optimize treatment for fractures. This article reviews cellular and molecular approaches to osteoporosis. Anabolic signals include growth factors and bone morphogenetic proteins. The responding stem cells of bone marrow stroma are inducible osteoprogenitor cells. The judicious use of local regulators in a focal systemic disease such as osteoporosis presents a formidable challenge. Gene therapy is likely to be an important therapeutic intervention. The integration of physical signals with chemical messengers regulating gene expression of bone cells is a useful future approach.

Original languageEnglish (US)
Pages (from-to)50-54
Number of pages5
JournalCurrent Opinion in Orthopaedics
Volume6
Issue number5
StatePublished - 1995
Externally publishedYes

Fingerprint

Osteoporosis
Bone and Bones
Bone Morphogenetic Proteins
Femur Neck
Genetic Therapy
Intercellular Signaling Peptides and Proteins
Spine
Stem Cells
Bone Marrow
Gene Expression
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Cellular and molecular approaches to osteoporosis. / Reddi, A Hari.

In: Current Opinion in Orthopaedics, Vol. 6, No. 5, 1995, p. 50-54.

Research output: Contribution to journalArticle

@article{44227546738d41f0a1795f956c0836e6,
title = "Cellular and molecular approaches to osteoporosis",
abstract = "Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone with increased susceptibility to fractures in focal sites such as femoral neck and lumbar spine. The current challenge is to optimize treatment for fractures. This article reviews cellular and molecular approaches to osteoporosis. Anabolic signals include growth factors and bone morphogenetic proteins. The responding stem cells of bone marrow stroma are inducible osteoprogenitor cells. The judicious use of local regulators in a focal systemic disease such as osteoporosis presents a formidable challenge. Gene therapy is likely to be an important therapeutic intervention. The integration of physical signals with chemical messengers regulating gene expression of bone cells is a useful future approach.",
author = "Reddi, {A Hari}",
year = "1995",
language = "English (US)",
volume = "6",
pages = "50--54",
journal = "Current Orthopaedic Practice",
issn = "1940-7041",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Cellular and molecular approaches to osteoporosis

AU - Reddi, A Hari

PY - 1995

Y1 - 1995

N2 - Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone with increased susceptibility to fractures in focal sites such as femoral neck and lumbar spine. The current challenge is to optimize treatment for fractures. This article reviews cellular and molecular approaches to osteoporosis. Anabolic signals include growth factors and bone morphogenetic proteins. The responding stem cells of bone marrow stroma are inducible osteoprogenitor cells. The judicious use of local regulators in a focal systemic disease such as osteoporosis presents a formidable challenge. Gene therapy is likely to be an important therapeutic intervention. The integration of physical signals with chemical messengers regulating gene expression of bone cells is a useful future approach.

AB - Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone with increased susceptibility to fractures in focal sites such as femoral neck and lumbar spine. The current challenge is to optimize treatment for fractures. This article reviews cellular and molecular approaches to osteoporosis. Anabolic signals include growth factors and bone morphogenetic proteins. The responding stem cells of bone marrow stroma are inducible osteoprogenitor cells. The judicious use of local regulators in a focal systemic disease such as osteoporosis presents a formidable challenge. Gene therapy is likely to be an important therapeutic intervention. The integration of physical signals with chemical messengers regulating gene expression of bone cells is a useful future approach.

UR - http://www.scopus.com/inward/record.url?scp=0028804734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028804734&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028804734

VL - 6

SP - 50

EP - 54

JO - Current Orthopaedic Practice

JF - Current Orthopaedic Practice

SN - 1940-7041

IS - 5

ER -